EcoDrugPlus

Melatonin Receptor 1a

Ensembl ID : ENSCMIG00000014790
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCMIG00000005621
Gene Symbol: MME
4 Cross references
280 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSCMIG00000004184
Gene Symbol: LOC103172906
3 Cross references
213 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSCMIG00000015112
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Microtubule-Associated Protein Tau-Like

Ensembl ID : ENSCMIG00000004127
Gene Symbol: LOC103190781
2 Cross references
227 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCMIG00000013905
Gene Symbol: MAPK1
4 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCMIG00000006833
Gene Symbol: MAPK10
3 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSCMIG00000015648
Gene Symbol: MAPK11
4 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSCMIG00000001746
Gene Symbol: MAPK14
4 Cross references
295 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSCMIG00000003993
Gene Symbol: MAPK8
4 Cross references
295 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSCMIG00000007089
Gene Symbol: MAPK9
4 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSCMIG00000018523
Gene Symbol: MAP2K1
4 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).